AG
SRRA

Algert Global’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Algert Global’s Portfolio SRRA Stock Details SRRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-1,992
Closed -$31K – 458
2019
Q3 		$31K Sell
1,992
-606
-23% -$11.6K 0.01% 351
2019
Q2 		$58K Buy
2,598
+578
+29% +$28K 0.02% 330
2019
Q1 		$138K Sell
2,020
-6,711
-77% -$431K 0.08% 267
2018
Q4 		$461K Sell
8,731
-1,125
-11% -$71.8K 0.13% 232
2018
Q3 		$670K Buy
9,856
+6,256
+174% +$567K 0.14% 217
2018
Q2 		$426K Buy
3,600
+3,012
+512% +$302K 0.09% 257
2018
Q1 		$49K Buy
+588
New +$66.7K 0.01% 322

Other funds holding SRRA

NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
HP
Hikari Power Tokyo, Japan $1.15B AUM 5.31% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
GT
Greenleaf Trust Kalamazoo, Michigan $10.2B AUM 2.09% 1-Year Est. Return

Algert Global's SRRA Position: Q4 2019 in Review

Algert Global sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q4 2019, closing a stake of 1,992 shares — an estimated $31K sold.

Algert Global first reported a position in SRRA in Q1 2018 and held it in 7 quarters. The position peaked at $670K in Q3 2018. 29 funds tracked by Wall St. Rank hold SRRA as of Q4 2019.

  • Algert Global reported no remaining Sierra Oncology, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • Algert Global sold 1,992 Sierra Oncology, Inc. Common Stock shares in Q4 2019, an estimated $31K.
  • Algert Global first reported a position in Sierra Oncology, Inc. Common Stock in Q1 2018 and held it in 7 quarters.
  • Algert Global's Sierra Oncology, Inc. Common Stock position peaked at $670K in Q3 2018.
  • 29 funds tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q4 2019.

Based on Algert Global's 13F filing for Q4 2019, filed 18 Feb 2020.